Florin Daniel P 4

What Happened

• Florin Daniel P, a director of Pulmonx Corp (LUNG), was granted 40,000 Restricted Stock Units (RSUs) on June 5, 2026. The Form 4 reports an acquisition at $0.00 per share (total reported value $0), reflecting a compensatory equity award rather than a cash purchase.

Key Details

• Transaction date: 2026-06-05; Form 4 filed: 2026-06-09.
• Transaction type/code: Award/Grant (coded "A" on the Form 4).
• Shares granted: 40,000 RSUs; reported acquisition price: $0.00; total reported acquisition value: $0.
• Shares owned after transaction: not specified in the filing.
• Footnote (F1): RSUs vest on the earlier of (i) the one-year anniversary of the grant (June 5, 2027, or next business day if that date is not a business day) or (ii) the date of the Annual Meeting of Stockholders for the year after the grant.
• Timeliness: Form 4 was filed 4 days after the transaction date; Form 4s are generally due within two business days, so investors may wish to verify timeliness if that matters to them.

Context

• RSUs are a compensation award that convert to shares only upon vesting; they are not an immediate open-market purchase or sale. Grants to directors are common as part of non-cash compensation and do not by themselves indicate a buy or sell signal.